Ma et al. reported that high expression of CCT6A and MYH9 was associated with shorter overall survival (OS) and DFS in patients with CRC liver metastasis, which suggests the potential prognostic value of CCT6A in this group of patients 11. Here, CCT6A is linked to colorectal carcinoma.